Michael Barbella, Managing Editor09.06.23
Forma Medical, an emerging innovator in medical device technologies, has launched OptimalHT, an instrumented minimally invasive surgery (MIS) hammertoe arthrodesis procedure. OptimalHT received U.S. Food and Drug Administration (FDA) approval in July as the company’s inaugural product launch and has treated more than 50 hammertoe deformities.
"It’s no secret that minimally invasive surgery is the future of foot and ankle care,” said Dr. Noman Siddiqui of LifeBridge Health in Baltimore. “The OptimalHT approach for digital correction is ideal for less invasive surgery in the foot to reduce edema, expedite recovery, and achieve the results my patients demand.”
Less invasive than other hammertoe-specific products on the market, OptimalHT is a uniquely instrumented procedure designed to provide repeatable outcomes with minimal incisions. It is also more cost effective and scalable than other attempts at hammertoe-specific products, according to the company.
"Receiving our first FDA approval and launching the OptimalHT system represents a pivotal moment for Forma Medical,” Forma Medical Vice President James Gault said. “With this FDA approval, we now have a platform to launch life-changing systems across multiple anatomies. We are continuing to push the envelope and expand our portfolio to advance patient care.”
According to the U.S. Census Bureau, the country is seeing unprecedented growth in the active aging population. With the number of people experiencing painful hammertoe deformities at an all-time high, and expected to rise, the need to better meet patient expectations is imperative.
“Retrograde k-wire fixation has been an acceptable treatment for decades, yet I've recently come to appreciate that some patients are returning to my practice years later with recurrent toe deformities. When I give them the choice, they also seem to be less tolerant of the pins sticking out of the toe and more inclined to pursue a quicker return to standard footwear,” noted Jesse Doty, M.D., of Erlanger Health System in Chattanooga, Tenn. “With OptimalHT, it's been seamless for me to incorporate the proven results of a k-wire or to take it a step further with more reliable fixation in a repeatable way that my patients find less inconvenient.”
Forma Medical will debut OptimalHT at the American Orthopedic Foot & Ankle Society (AOFAS) Annual Meeting (Sept. 20-23).
"It’s no secret that minimally invasive surgery is the future of foot and ankle care,” said Dr. Noman Siddiqui of LifeBridge Health in Baltimore. “The OptimalHT approach for digital correction is ideal for less invasive surgery in the foot to reduce edema, expedite recovery, and achieve the results my patients demand.”
Less invasive than other hammertoe-specific products on the market, OptimalHT is a uniquely instrumented procedure designed to provide repeatable outcomes with minimal incisions. It is also more cost effective and scalable than other attempts at hammertoe-specific products, according to the company.
"Receiving our first FDA approval and launching the OptimalHT system represents a pivotal moment for Forma Medical,” Forma Medical Vice President James Gault said. “With this FDA approval, we now have a platform to launch life-changing systems across multiple anatomies. We are continuing to push the envelope and expand our portfolio to advance patient care.”
According to the U.S. Census Bureau, the country is seeing unprecedented growth in the active aging population. With the number of people experiencing painful hammertoe deformities at an all-time high, and expected to rise, the need to better meet patient expectations is imperative.
“Retrograde k-wire fixation has been an acceptable treatment for decades, yet I've recently come to appreciate that some patients are returning to my practice years later with recurrent toe deformities. When I give them the choice, they also seem to be less tolerant of the pins sticking out of the toe and more inclined to pursue a quicker return to standard footwear,” noted Jesse Doty, M.D., of Erlanger Health System in Chattanooga, Tenn. “With OptimalHT, it's been seamless for me to incorporate the proven results of a k-wire or to take it a step further with more reliable fixation in a repeatable way that my patients find less inconvenient.”
Forma Medical will debut OptimalHT at the American Orthopedic Foot & Ankle Society (AOFAS) Annual Meeting (Sept. 20-23).